publication venue for
- Mapping frameworks for synthesizing qualitative evidence in health technology assessment.. 40:e53. 2024
- Content validation of the COST for patient questionnaire (COPAQ) for patients with low back pain: a qualitative study.. 40:e46. 2024
- Application of natural language processing to predict final recommendation of Brazilian health technology assessment reports. 40:e19. 2024
- Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône–Alps region in France. 39:e5. 2023
- Addressing uncertainty in relative effectiveness assessments by HTA organizations. 38:e17. 2022
- Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling. 38:e57. 2022
- Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force. 38:e37. 2022
- An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency. 37:e37. 2021
- Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries. 36:440-444. 2020
- Impact of rarity on Canadian oncology health technology assessment and funding. 36:404-409. 2020
- Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model. 36:317-324. 2020
- Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective. 36:29-33. 2020
- Commentary. In Praise of Studies That Use More Than One Generic Preference-Based Measure. 35:257-262. 2019
- Ethical Challenges Related to Patient Involvement in Health Technology Assessment. 35:253-256. 2019
- Health Technology Agency insights: informing modification of a qualitative benefit risk framework for Health Technology Reassessment of prescription medications. 35:384-392. 2019
- DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT. 34:290-299. 2018
- OP118 Women's Preferences And Perspectives On Cervical Cancer Screening. 34:44-44. 2018
- OP119 Appraising Qualitative Research For Qualitative Evidence Syntheses. 34:44-45. 2018
- OP80 Reconciling Ethical And Economic Notions Of ‘Value’ For HTA. 34:29-30. 2018
- OP82 Ethical Challenges Related To Engaging Patients And The Public In HTA. 34:30-30. 2018
- PP51 Updating Canadian Pharmaceutical Budget Impact Analysis Guidelines. 34:86-86. 2018
- PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project. 34:100-101. 2018
- DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS. 33:261-269. 2017
- GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS. 33:176-182. 2017
- REFLECTIONS ON THE NICE DECISION TO REJECT PATIENT PRODUCTION LOSSES. 33:638-643. 2017
- VP57 Test-Retest Reliability Analysis Of The Patient Reported Outcomes Burdens And Experiences (PROBE) Study Questionnaire Test-Retest Reliability Analysis Of The PROBE Study Questionnaire. 33:174-175. 2017
- ASPECTS OF PATIENT REPORTED OUTCOMES IN RARE DISEASES: A DISCUSSION PAPER. 32:126-130. 2016
- PATIENT-REPORTED OUTCOMES IN RARE LYSOSOMAL STORAGE DISEASES: KEY INFORMANT INTERVIEWS AND A SYSTEMATIC REVIEW PROTOCOL. 32:393-399. 2016
- PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION. 32:256-264. 2016
- BARRIERS AND FACILITATORS INFLUENCING ETHICAL EVALUATION IN HEALTH TECHNOLOGY ASSESSMENT. 31:113-123. 2015
- ECONOMIC EVALUATION OF AN INFLUENZA IMMUNIZATION STRATEGY OF HEALTHY CHILDREN. 30:394-399. 2014
- GENERATING HEALTH TECHNOLOGY ASSESSMENT EVIDENCE FOR RARE DISEASES. 30:416-422. 2014
- ASSESSING THE IMPACTS OF CITIZEN DELIBERATIONS ON THE HEALTH TECHNOLOGY PROCESS – ERRATUM. 29:466-466. 2013
- ASSESSING THE IMPACTS OF CITIZEN DELIBERATIONS ON THE HEALTH TECHNOLOGY ASSESSMENT PROCESS. 29:282-289. 2013
- HYPERBARIC OXYGEN THERAPY FOR DIABETIC ULCERS: SYSTEMATIC REVIEW AND META-ANALYSIS. 29:269-281. 2013
- CANADIAN CANCER RISK MANAGEMENT MODEL: EVALUATION OF CANCER CONTROL. 29:131-139. 2013
- Erratum: Assessing the impacts of citizen deliberations on the health technology process-Erratum (International Journal of Technology Assessment in Health Care 19:3 (282-2289) Doi:.10.1017/S0266462313000299). 29:466. 2013
- MATHEMATICAL MODELING: THE CASE OF EMERGENCY DEPARTMENT WAITING TIMES. 28:93-109. 2012
- Cost-effectiveness analysis of cast versus splint in children with acceptably angulated wrist fractures. 27:101-107. 2011
- Coverage with evidence development: The Ontario experience. 27:159-168. 2011
- Moving cautiously: Public involvement and the health technology assessment community. 27:43-49. 2011
- Supporting the use of health technology assessments in policy making about health systems. 26:405-414. 2010
- EVIPNet Africa's first series of policy briefs to support evidence-informed policymaking. 26:229-232. 2010
- Ethics in Canadian health technology assessment: A descriptive review. 25:463-469. 2009
- Handling uncertainty in economic evaluations of patient level data: A review of the use of Bayesian methods to inform health technology assessments. 25:546-554. 2009
- Health technology assessment in Canada. 25:53-60. 2009
- The “natural history” of health technology assessment. 25:281-284. 2009
- Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. 25:196-207. 2009
- Health technology assessment: A comprehensive framework for evidence-based recommendations in Ontario. 25:141-150. 2009
- In search of the evidentiary foundation of published Canadian economic evaluations (2001–06). 25:214-221. 2009
- Health-related quality of life measures in routine clinical care: Can FACT-Fatigue help to assess the management of fatigue in cancer patients?. 25:90-96. 2009
- Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?. 24:437-444. 2008
- Utilization patterns of diagnostic imaging across the late life course: A population-based study in Ontario, Canada. 24:384-390. 2008
- Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. 24:87-95. 2008
- Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. 23:299-309. 2007
- Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil. 23:126-130. 2007
- Primary data collection in health technology assessment. 23:24-29. 2007
- Measuring quality of life: The development and initial validation of the Patient-Reported Erectile Function Assessment instrument. 22:372-378. 2006
- A test of prospect theory. 21:511-516. 2005
- Test–retest reliability of health utilities index scores: Evidence from hip fracture. 21:393-398. 2005
- Clinicians' assessments of practice guidelines in oncology: The CAPGO survey. 20:421-426. 2004
- Use of systematic reviews in the development of new provincial public health policies in Ontario. 20:399-404. 2004
- Comparing short form and RAND physical and mental health summary scores: Results from total hip arthroplasty and high-risk primary-care patients. 20:230-235. 2004
- HEALTH-RELATED QUALITY OF LIFE MEASURE BASED ON THE MINIMUM DATA SET. 19:490-506. 2003
- COMPARING COMMUNITY-PREFERENCE–BASED AND DIRECT STANDARD GAMBLE UTILITY SCORES: EVIDENCE FROM ELECTIVE TOTAL HIP ARTHROPLASTY. 19:362-372. 2003
- CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA. 19:301-316. 2003
- CHARACTERISTICS OF HIGH-QUALITY GUIDELINES. 19:148-157. 2003
- FACTORS OF THE INNOVATION, ORGANIZATION, ENVIRONMENT, AND INDIVIDUAL THAT PREDICT THE INFLUENCE FIVE SYSTEMATIC REVIEWS HAD ON PUBLIC HEALTH DECISIONS. 17:467-478. 2001
- FACTORS AFFECTING THE UTILIZATION OF SYSTEMATIC REVIEWS. 17:203-214. 2001
- BREAST CANCER: BETTER CARE FOR LESS COST Is It Possible?. 16:1168-1178. 2000
- USING PRACTICE GUIDELINES TO ALLOCATE MEDICAL TECHNOLOGIES An Ethics Framework. 16:987-1002. 2000
- POPULATION-BASED AND OPPORTUNISTIC SCREENING AND ERADICATION OF HELICOBACTER PYLORI. 15:649-660. 1999
- Evaluating Treatments for Childhood Cancer: A Process for Critical Appraisal of the Literature and a Summary of the Results. 11:1-10. 1995
- Evaluation of the Canadian Coordinating Office for Health Technology Assessment. 11:102-116. 1995
- The Development of Health Care Technology Assessment:An International Perspective. 11:286-300. 1995
- Economic Evaluation of A Support Program for Caregivers of Demented Elderly. 7:209-219. 1991
- Contributors. 5:679-680. 1989
- Research Methods for Obtaining Primary Evidence. 5:503-519. 1989
- Utilities and Quality-Adjusted Life Years. 5:559-575. 1989
- Guidelines for Health Technology Assessment. 1:873-892. 1985
- Guidelines for the Clinical and Economic Assessment of Health Technologies. 1:551-566. 1985
- Neglected Issues in the Diffusion of Health Care Technologies:The Role of Skills and Learning. 1:681-692. 1985